XIFIN Enters Radiology RCM Services Segment with Computerized Management Services Acquisition

  • Jul 7, 2021

Radiology RCM services deal underscores XIFIN’s commitment to providing the diagnostic health industry with deep expertise, advanced business intelligence and analytics critical for optimizing operations San Diego, Calif. – July 7, 2021 - XIFIN today announced the acquisition of Computerized Management Services (CMS), a provider of revenue cycle management (RCM) services for radiology groups...

Read


XIFIN Establishing Operations in South Carolina

  • Jun 29, 2021

Healthcare revenue cycle company to create more than 150 new jobs over the next two years COLUMBIA, S.C. – XIFIN, a national leader in revenue cycle management (RCM) for diagnostic providers, today announced plans to establish operations in Berkeley County. The company’s new East Coast location will create more than 150 new jobs over the next two years. With over 20 years of experience helping...

Read


XIFIN Executives to Share Insights for Driving 15% Increase in Outpatient and Ancillary Services Profit in Upcoming HFMA Webinar

  • Apr 21, 2021

Recently-promoted COO joins XIFIN CEO and HFMA research lead to discuss how outpatient-specific RCM optimizes operational visibility and revenue versus traditional EHRs. SAN DIEGO, Calif., — April 21, 2021 — In an upcoming Healthcare Financial Management Association (HFMA) member webinar, XIFIN Executive Chairman and CEO Lâle White and Kyle Fetter, recently promoted to chief operating officer at...

Read


XIFIN Innovation Drives Growth in Four Key Business Areas Amid COVID-19 Pandemic

  • Jan 27, 2021

Company executives predict diagnostic volume surge remains through Q1, rise in antibody testing imminent SAN DIEGO, Calif., — January 27, 2021 — Following a year that has redefined the diagnostic laboratory industry and healthcare at large, XIFIN experienced strong growth in four key areas in 2020, with expectations of continued momentum into the new year. This includes expansion into digital...

Read


XIFIN Solutions Recognized by Black Book Research for Four Consecutive Years

  • Nov 10, 2020

Company’s Revenue Cycle Management (RCM) Voted #1 Client Rated Solution by Diagnostic Labs SAN DIEGO, Calif., — November 10, 2020 — 2020 has been a year unlike any other, especially for the healthcare industry. Diagnostic providers, in particular, have faced numerous challenges as they manage a rollercoaster of testing volumes – and associated claims and revenue implications – driven...

Read


XIFIN Launches RPM 12 to Accelerate Workflow and Improve Financial Performance for Diagnostic Providers Amid COVID-19

  • Sep 29, 2020
  • San Diego, CA

Expanded Capabilities, Including Advanced Analytics, Client & Patient Portals, and Insurance Discovery Enable More Efficient Management of Revenue Cycles and Collections SAN DIEGO, Calif., - September 30, 2020 – Diagnostic providers across the U.S. are overwhelmed by a high number of testing volumes – on average, 165% of their normal levels –   as the country continues to...

Read


XIFIN Executives Expect 15% Increase in Fall COVID-19 Testing Volumes; Seeing Regional Labs Pick Up Overflow from Larger, National Players

  • Sep 22, 2020
  • San Diego, CA

Company highlights key factors expected to impact Q4 COVID-19 testing during UBS analyst event SAN DIEGO, Calif., - September 22, 2020 – COVID-19 has impacted diagnostic volumes, mix and reimbursement for a variety of diagnostic providers. As the nation transitions into fall, new challenges will arise for the laboratory industry as students go back to school and flu season hits its peak. XIFIN...

Read


XIFIN LIS 7 Helps Laboratories Process Increased Testing Volumes Due to COVID-19 Crisis

  • Sep 11, 2020
  • San Diego, CA

New Capabilities, Including Dolbey Fusion Narrate, Drive Increased Productivity and Patient Throughput Amid Surge SAN DIEGO, Calif., — September 11, 2020 — The COVID-19 pandemic has created an overwhelming demand for testing, with laboratories nationwide seeing, on average, testing volumes at 1.6 times their normal levels. This pressure demonstrates the need for technology that not only...

Read